A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12)
Article in OncoImmunology (June 2024)
The most recent citing publications are shown below. View all 127 publications that cite this research output on Dimensions.
Article in OncoImmunology (June 2024)
Article in Clinical Imaging (June 2024)
Article in International Journal of Surgery Case Reports (June 2024)